|1||Active, not recruiting||
An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations
Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy
|4||Active, not recruiting||
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
† Study has passed its completion date and status has not been verified in more than two years.